Literature DB >> 6657043

Effectiveness of Soviet-produced human somatotropin in the treatment of hypothalamo-pituitary dwarfism.

D G Lashene.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6657043     DOI： 10.1007/BF01190796

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN： 0097-0549


× No keyword cloud information.
  7 in total

1.  Treatment of a pituitary dwarf with human growth hormone.

Authors:  M S RABEN
Journal:  J Clin Endocrinol Metab       Date:  1958-08       Impact factor: 5.958

2.  Growth and growth hormone. II. A comparison of isolated growth-hormone deficiency and multiple pituitary-hormone deficiencies in 35 patients with idiopathic hypopituitary dwarfism.

Authors:  H G Goodman; M M Grumbach; S L Kaplan
Journal:  N Engl J Med       Date:  1968-01-11       Impact factor: 91.245

Review 3.  Human growth hormone and hypopituitargrowth retardation.

Authors:  O Trygstad
Journal:  Acta Paediatr Scand       Date:  1969-07

4.  Endocrine causes of short stature.

Authors:  S Raiti
Journal:  Postgrad Med       Date:  1977-12       Impact factor: 3.840

5.  Long-term treatment with human growth hormone (Raben) in small doses. Evaluation of 18 hypopituitary patients.

Authors:  A Prader; M Zachmann; J R Poley; R Illig; J Széky
Journal:  Helv Paediatr Acta       Date:  1967-10

6.  [Clinical use of Soviet-made human somatotropin preparation. 1. Dynamics of physical development].

Authors:  N A Zarubina; A L Sinitsyna; Iu K Danis; L V Lashas; D G Lashene
Journal:  Probl Endokrinol (Mosk)       Date:  1978 May-Jun

7.  Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints.

Authors:  J M Tanner; R H Whitehouse; P C Hughes; F P Vince
Journal:  Arch Dis Child       Date:  1971-12       Impact factor: 3.791
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.